pass and the mean activation in this group was 6.4%. There was no significant difference between the three groups in complement activation. In group 2, however, women showed significantly more complement activation than men (p <0 05).
however, between raised serum concentrations of 8 aminolaevulinic acid and neurodysfunction. All four types of acute porphyria, in which concentrations of 8 aminolaevulinic acid are raised, are characterised by neurological dysfunction whereas the non-acute porphyrias, which have normal concentrations of 8 aminolaevulinic acid, are not. Furthermore, peripheral neuropathy is a feature of lead poisoning and hereditary tyrosinaemia, in which blood concentrations of 8 aminolaevulinic acid are raised.
Intravenous infusion of haematin, which represses activity of 8 aminolaevulinic acid synthase and hence lowers the increased blood concentrations of 8 aminolaevulinic acid and porphobilinogen, provides some benefit in acute porphyria.5 Tishler et all 2 reported that activated charcoal cartridges effectively removed large amounts of porphyrins and their precursors from solution in vitro, these amounts being considerably greater than estimated daily production during an attack of porphyria. The removal of 8 aminolaevulinic acid and porphobilinogen and possibly other neurotoxic compounds by haemoperfusion through such sorbents might favourably alter the course of acute attacks.
In our study haemoperfusion with activated charcoal columns coupled with haemodialysis considerably reduced serum concentrations of 8 aminolaevulinic acid and porphobilinogen with a concomitant decrease in urinary porphyrin precursors; but serum concentrations had returned to pretreatment values within 24 hours and abdominal pain was not relieved after four days' treatment. We cannot exclude the possibility that a longer course of treatment might have had a more favourable outcome, but this seems unlikely in view of the rapid rebound of serum concentrations of 8 aminolaevulinic acid after each haemoperfusion. Furthermore, the resulting thrombocytopenia might present a major limiting factor to such treatnent.
We thank Professor Sir Abraham Goldberg for his guidance.
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Tishler into an antibody containing gel (fig 1) . Our method consisted of a four hour separation at 12-5 volts/cm in the first dimension followed by a 17 hour separation at 4 volts/cm in the second dimension. The antiserum was antihuman C3c (Hoechst UK Limited) and was used at a concentration of 2-3%. Disodium edetic acid was used throughout the assay at a concentration of 0-01 mmol/l to prevent in vitro conversion of complement.17 Negative and positive controls were prepared, stored at -70°C, and included in all plates. Lipopolysaccaride (Difco Laboratories) was used to produce C3 conversion in normal serum, and a dose response curve was also set up. After running, the plates were washed, dried, and stained. The area enclosed by the individual precipitate is proportional to the amount of antigen. We measured the peak areas by planimetry" and then calculated the conversion as follows: % conversion= (area of converted C3 peak (C3c))/(area of converted +area of unconverted peak) x 100. Stored blood was also examined to determine if activated complement was possibly transfused. The effect of aging on serum was studied by examining samples kept at room temperature, 4°C, and 37°C for 24 hours.
The relatively large number of patients with C3 conversion results below the measurement limits of our method necessitated a means of ranking in such cases. We decided to use the peak height alone because this was obtainable in all but a very few cases. Although this is not satisfactory as a method of measuring C3 conversion it was found to correlate well with C3 conversions where available: conversion (3) level v ratio (3) p < 0-01; conversion (4) level v ratio (4) p < 0-01. The ratio values known as R (3) and R (4) were calculated as follows: ratio R = (height of converted C3 peak)/(height of unconverted C3 peak) x 100. The patients were then ranked according to their overall C3 conversion results, where available, or to the peak height ratio figures as defined above. Dilution of plasma due to mixing the pump prime was compensated for by consideration of change in packed cell volume in prebypass sample compared with a sample taken on bypass. The mean dilution going on to bypass was 1-5 (SD =0-15).
To determine which of the many factors including age, sex, nature of operation, temperature of bypass, surgeon, ischaemic time, etc were related significantly to either C3 or C4 levels or C3 conversion, multiple correlation coefficients were determined using corrections for significance."' Student's t tests for parametric results and MannWhitney U tests for non-parametric results were carried out where appropriate. In addition, analysis of frequencies was carried out by the X2 test (table I) . As shown in table II and figure 3 there was a difference between men and women in the rapidity with which complement activation became evident during bypass. Although women already had activation in sample 3, men in general only developed significant activation in sample 4 (fig 3) . The difference in complement activation in the normothermic and hypothermic groups (table II) was not biased by a difference in the proportion of cooled patients in the male and female groups. Finally, in contrast with the notable differences shown between women and men in group 2, the pooled data (groups 1, 2, and 3) gave differences only for the first sample taken during bypass (sample 3). A total of 8 (18%) of all patients showed a fall in C4 concentrations on bypass of more than 10%. Analysis by Student's t test showed a significant fall in C4 during the first 30 minutes on bypass for all groups (p <0-05) and also C4 concentrations showed a significant rise between induction and the start of cardiopulmonary bypass (p <0-005). Further analysis by correlation coefficients showed that women in group 1 had a greater decrease in C4 concentrations than men during the first 30 minutes of cardiopulmonary bypass. Also in group 1, the changes in C4 concentrations during 30 to 60 minutes on bypass were not related to the type of operation. In group 3 (pulsatile flow), however, the concentrations of C4 after 30 minutes on bypass were higher in those having the valve than in those having the coronary artery bypass graft (p < 0-02). Complement activation was not detected in the three units of stored blood given to patients during the bypass period. Complement activation was, however, detected in the aged serum at 24 hours. The levels were 23% at 37°C, <4-5% at room temperature, and <4-5% at 4°C.
A total of 20 (45%) of all patients showed measurable C3 activation in at least one sample on bypass. The percentage of patients affected in groups 2 or 3 was not significantly different from that in group 1. Examination of the crossed immunoelectrophoresis plates showed that the negative controls and the patients' samples before bypass were consistently negative. The coefficient of variation of the positive controls was 4-5%, confirming the reliability of the method. Table II shows the correlation of complement activation in samples taken during bypass (samples 3 and 4), carried out using the Mann-
Discussion
The ability to detect in vivo complement activation is critically dependent on the laboratory technique used. We have shown that the method described by inhibiting in vitro complement activation and using the same control serum on all plates in the study is reliable (coefficient of variation 4-5%). We used 0-01 mmol/1 sodium edetic acid, and the control plates were consistently negative. A previous study used only 0-0025 mmol/l edetic acid,6 but complement activation was shown in samples of stored blood and non-cardiac patient controls. C3 activation in stored blood has not been detected either by us or by other workers using the same technique. The value of determining concentrations of C3 and C4 as antigen has been debated by previous workers. C4 and to a lesser extent C3 are acute reactive proteins and sudden rises could be expected during the bypass procedure, which might tend to offset any depletion due to in vivo activation. A correction factor to take into account haemodilution from the pump prime must be applied, but it can be seen that true depletion occurred both in this study (fig 1) and in another. 9 The role of corticosteroids has been little studied. No previous investigation has administered the drug in two doses to take account of the dilution shown by Thompson et al1.2 In single dose studies in two patients,6 and in another in five patients,22 the authors concluded that steroids had no effect. Although we also could show no difference in activation in those patients who received the steroid compared with controls, the difference between men and women seen in the steroid group is of considerable interest. In the recent study by Boralessa and colleagues only men were examined.9 We cannot explain the apparent increase in complement activation seen in this subgroup but it is surprising, as steroids may suppress the immune response by their lysosome-stabilising activity.13 A previous study using a single dose of steroid found no difference in lung function.3 The role of pulsatile flow has not been elucidated here in relation to any complement related benefit. This study on a group of only 10 patients was sufficient for statistical analysis but requires extension before firm conclusions can be drawn.
It would be useful to relate change in complement activation to clinical outcome. Because of the many surgical factors an extremely large study would be necessary. In our study of 44 patients, three died in the perioperative period, all of whom had received methylprednisolone, but obviously no conclusion can be drawn. Our patients all underwent perfusion through a bubble oxygenator. This might be expected to cause both more trauma to the cellular elements of the blood and greater complement activation than a membrane oxygenator. Previous comparative studies22 have been too small to allow any conclusions to be derived.
Conclusion
We have confirmed that crossed immunoelectrophoresis is a reliable method of quantifying C3 activation in vivo provided that the technique described is followed. Complement activation of the order of 5% to 12% was detected in a significant number of patients during bypass and it is suggested that neither corticosteroids nor pulsatile flow effect this. The finding of increased levels of complement activation in women who received methylprednisolone might suggest caution with its use in this group of patients. 
